▶ 調査レポート

連続皮下インスリン注入装置の世界市場 2020年

• 英文タイトル:Global Continuous Subcutaneous Insulin Infusion Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。連続皮下インスリン注入装置の世界市場 2020年 / Global Continuous Subcutaneous Insulin Infusion Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / GIR201102877資料のイメージです。• レポートコード:GIR201102877
• 出版社/出版日:GlobalInfoResearch / 2020年10月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、連続皮下インスリン注入装置の世界市場を調査対象にし、連続皮下インスリン注入装置の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(ノーマルポンプ、パッチポンプ)、用途別分析(I型糖尿病、II型糖尿病)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:Medtronic、Tandem Diabetes care、Roche、Microport、Insulet Corp、SOOIL、Valeritas
・メーカー別販売量、売上、市場シェア
・連続皮下インスリン注入装置の地域別市場分析
・連続皮下インスリン注入装置の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・連続皮下インスリン注入装置のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・連続皮下インスリン注入装置のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・連続皮下インスリン注入装置の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・連続皮下インスリン注入装置の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・連続皮下インスリン注入装置の種類別市場規模2015-2020:ノーマルポンプ、パッチポンプ
・連続皮下インスリン注入装置の用途別市場規模2015-2020:I型糖尿病、II型糖尿病
・連続皮下インスリン注入装置の世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論

Market Overview
The Continuous Subcutaneous Insulin Infusion Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Continuous Subcutaneous Insulin Infusion Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Continuous Subcutaneous Insulin Infusion Devices market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Continuous Subcutaneous Insulin Infusion Devices market has been segmented into
Normal Pump
Patch Pump

By Application, Continuous Subcutaneous Insulin Infusion Devices has been segmented into:
Type I Diabetes
Type II Diabetes

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Continuous Subcutaneous Insulin Infusion Devices market presented in the report. This section sheds light on the sales growth of different regional and country-level Continuous Subcutaneous Insulin Infusion Devices markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Continuous Subcutaneous Insulin Infusion Devices market.

The report offers in-depth assessment of the growth and other aspects of the Continuous Subcutaneous Insulin Infusion Devices market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Continuous Subcutaneous Insulin Infusion Devices Market Share Analysis
Continuous Subcutaneous Insulin Infusion Devices competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Continuous Subcutaneous Insulin Infusion Devices sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Continuous Subcutaneous Insulin Infusion Devices sales, revenue and market share for each player covered in this report.

The major players covered in Continuous Subcutaneous Insulin Infusion Devices are:
Medtronic
Tandem Diabetes care
Roche
Microport
Insulet Corp
SOOIL
Valeritas

Among other players domestic and global, Continuous Subcutaneous Insulin Infusion Devices market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Continuous Subcutaneous Insulin Infusion Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Continuous Subcutaneous Insulin Infusion Devices, with price, sales, revenue and global market share of Continuous Subcutaneous Insulin Infusion Devices in 2018 and 2019.
Chapter 3, the Continuous Subcutaneous Insulin Infusion Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Continuous Subcutaneous Insulin Infusion Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Continuous Subcutaneous Insulin Infusion Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Continuous Subcutaneous Insulin Infusion Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Continuous Subcutaneous Insulin Infusion Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Normal Pump
1.2.3 Patch Pump
1.3 Market Analysis by Application
1.3.1 Overview: Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Overview of Global Continuous Subcutaneous Insulin Infusion Devices Market
1.4.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Tandem Diabetes care
2.2.1 Tandem Diabetes care Details
2.2.2 Tandem Diabetes care Major Business
2.2.3 Tandem Diabetes care SWOT Analysis
2.2.4 Tandem Diabetes care Product and Services
2.2.5 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche SWOT Analysis
2.3.4 Roche Product and Services
2.3.5 Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Microport
2.4.1 Microport Details
2.4.2 Microport Major Business
2.4.3 Microport SWOT Analysis
2.4.4 Microport Product and Services
2.4.5 Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Insulet Corp
2.5.1 Insulet Corp Details
2.5.2 Insulet Corp Major Business
2.5.3 Insulet Corp SWOT Analysis
2.5.4 Insulet Corp Product and Services
2.5.5 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 SOOIL
2.6.1 SOOIL Details
2.6.2 SOOIL Major Business
2.6.3 SOOIL Product and Services
2.6.4 SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Valeritas
2.7.1 Valeritas Details
2.7.2 Valeritas Major Business
2.7.3 Valeritas Product and Services
2.7.4 Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Continuous Subcutaneous Insulin Infusion Devices Manufacturer Market Share in 2019
3.3.2 Top 6 Continuous Subcutaneous Insulin Infusion Devices Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales and Market Share by Regions (2015-2020)
4.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Regions (2015-2020)
4.2 North America Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
4.3 Europe Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
4.5 South America Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Market Share by Country
5.1.1 North America Continuous Subcutaneous Insulin Infusion Devices Sales and Market Share by Country (2015-2020)
5.1.2 North America Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Country (2015-2020)
5.2 United States Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
5.3 Canada Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
5.4 Mexico Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Market Share by Country
6.1.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales and Market Share by Country (2015-2020)
6.1.2 Europe Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Country (2015-2020)
6.2 Germany Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
6.3 UK Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
6.4 France Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
6.5 Russia Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
6.6 Italy Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Regions (2015-2020)
7.2 China Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
7.3 Japan Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
7.4 Korea Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
7.5 India Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
7.7 Australia Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Market Share by Country
8.1.1 South America Continuous Subcutaneous Insulin Infusion Devices Sales and Market Share by Country (2015-2020)
8.1.2 South America Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Country (2015-2020)
8.2 Brazil Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
8.3 Argentina Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
9.3 Turkey Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
9.4 Egypt Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
9.5 South Africa Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales and Market Share by Type (2015-2020)
10.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Type (2015-2020)
10.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2015-2020)
11 Global Continuous Subcutaneous Insulin Infusion Devices Market Segment by Application
11.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2015-2020)
11.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2015-2020)
11.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2015-2020)
12 Market Forecast
12.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Growth Rate (2021-2025)
12.2 Continuous Subcutaneous Insulin Infusion Devices Market Forecast by Regions (2021-2025)
12.2.1 North America Continuous Subcutaneous Insulin Infusion Devices Market Forecast (2021-2025)
12.2.2 Europe Continuous Subcutaneous Insulin Infusion Devices Market Forecast (2021-2025)
12.2.3 Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Market Forecast (2021-2025)
12.2.4 South America Continuous Subcutaneous Insulin Infusion Devices Market Forecast (2021-2025)
12.2.5 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Market Forecast (2021-2025)
12.3 Continuous Subcutaneous Insulin Infusion Devices Market Forecast by Type (2021-2025)
12.3.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Type (2021-2025)
12.3.2 Global Continuous Subcutaneous Insulin Infusion Devices Market Share Forecast by Type (2021-2025)
12.4 Continuous Subcutaneous Insulin Infusion Devices Market Forecast by Application (2021-2025)
12.4.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Application (2021-2025)
12.4.2 Global Continuous Subcutaneous Insulin Infusion Devices Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Continuous Subcutaneous Insulin Infusion Devices by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Continuous Subcutaneous Insulin Infusion Devices Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Medtronic Basic Information, Manufacturing Base and Competitors
Table 9. Medtronic Continuous Subcutaneous Insulin Infusion Devices Major Business
Table 10. Medtronic Continuous Subcutaneous Insulin Infusion Devices Total Revenue (USD Million) (2018-2019)
Table 11. Medtronic SWOT Analysis
Table 12. Medtronic Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 13. Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Tandem Diabetes care Basic Information, Manufacturing Base and Competitors
Table 15. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Major Business
Table 16. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Total Revenue (USD Million) (2018-2019)
Table 17. Tandem Diabetes care SWOT Analysis
Table 18. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 19. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Roche Basic Information, Manufacturing Base and Competitors
Table 21. Roche Continuous Subcutaneous Insulin Infusion Devices Major Business
Table 22. Roche Continuous Subcutaneous Insulin Infusion Devices Total Revenue (USD Million) (2018-2019)
Table 23. Roche SWOT Analysis
Table 24. Roche Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 25. Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Microport Basic Information, Manufacturing Base and Competitors
Table 27. Microport Continuous Subcutaneous Insulin Infusion Devices Major Business
Table 28. Microport Continuous Subcutaneous Insulin Infusion Devices Total Revenue (USD Million) (2018-2019)
Table 29. Microport SWOT Analysis
Table 30. Microport Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 31. Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Insulet Corp Basic Information, Manufacturing Base and Competitors
Table 33. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Major Business
Table 34. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Total Revenue (USD Million) (2018-2019)
Table 35. Insulet Corp SWOT Analysis
Table 36. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 37. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. SOOIL Basic Information, Manufacturing Base and Competitors
Table 39. SOOIL Continuous Subcutaneous Insulin Infusion Devices Major Business
Table 40. SOOIL Continuous Subcutaneous Insulin Infusion Devices Total Revenue (USD Million) (2018-2019)
Table 41. SOOIL SWOT Analysis
Table 42. SOOIL Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 43. SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Valeritas Basic Information, Manufacturing Base and Competitors
Table 45. Valeritas Continuous Subcutaneous Insulin Infusion Devices Major Business
Table 46. Valeritas Continuous Subcutaneous Insulin Infusion Devices Total Revenue (USD Million) (2018-2019)
Table 47. Valeritas SWOT Analysis
Table 48. Valeritas Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 49. Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Manufacturer (2018-2019) (K Units)
Table 51. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Manufacturer (2018-2019) (USD Million)
Table 52. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Regions (2015-2020) (K Units)
Table 53. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Regions (2015-2020)
Table 54. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Regions (2015-2020) (USD Million)
Table 55. North America Continuous Subcutaneous Insulin Infusion Devices Sales by Countries (2015-2020) (K Units)
Table 56. North America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Countries (2015-2020)
Table 57. North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Countries (2015-2020) (USD Million)
Table 58. North America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Countries (2015-2020)
Table 59. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Countries (2015-2020) (K Units)
Table 60. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Countries (2015-2020)
Table 61. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Countries (2015-2020) (USD Million)
Table 62. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Regions (2015-2020) (K Units)
Table 63. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Regions (2015-2020)
Table 64. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Regions (2015-2020) (USD Million)
Table 65. South America Continuous Subcutaneous Insulin Infusion Devices Sales by Countries (2015-2020) (K Units)
Table 66. South America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Countries (2015-2020)
Table 67. South America Continuous Subcutaneous Insulin Infusion Devices Revenue by Countries (2015-2020) (USD Million)
Table 68. South America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Countries (2015-2020)
Table 69. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Countries (2015-2020) (K Units)
Table 70. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Countries (2015-2020)
Table 71. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Countries (2015-2020) (USD Million)
Table 72. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Countries (2015-2020)
Table 73. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2015-2020) (K Units)
Table 74. Global Continuous Subcutaneous Insulin Infusion Devices Sales Share by Type (2015-2020)
Table 75. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2015-2020) (USD Million)
Table 76. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Share by Type (2015-2020)
Table 77. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2015-2020) (K Units)
Table 78. Global Continuous Subcutaneous Insulin Infusion Devices Sales Share by Application (2015-2020)
Table 79. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Regions (2021-2025) (K Units)
Table 80. Global Continuous Subcutaneous Insulin Infusion Devices Market Share Forecast by Regions (2021-2025)
Table 81. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Type (2021-2025) (K Units)
Table 82. Global Continuous Subcutaneous Insulin Infusion Devices Market Share Forecast by Type (2021-2025)
Table 83. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Application (2021-2025)
Table 84. Global Continuous Subcutaneous Insulin Infusion Devices Market Share Forecast by Application (2021-2025)
Table 85. Direct Channel Pros & Cons
Table 86. Indirect Channel Pros & Cons
Table 87. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Continuous Subcutaneous Insulin Infusion Devices Picture
Figure 2. Global Sales Market Share of Continuous Subcutaneous Insulin Infusion Devices by Type in 2019
Figure 3. Normal Pump Picture
Figure 4. Patch Pump Picture
Figure 5. Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application in 2019
Figure 6. Type I Diabetes Picture
Figure 7. Type II Diabetes Picture
Figure 8. Global Continuous Subcutaneous Insulin Infusion Devices Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Continuous Subcutaneous Insulin Infusion Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Manufacturer in 2019
Figure 29. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Continuous Subcutaneous Insulin Infusion Devices Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Continuous Subcutaneous Insulin Infusion Devices Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Regions (2015-2020)
Figure 36. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Regions in 2018
Figure 37. North America Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
Figure 38. Europe Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
Figure 40. South America Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020)
Figure 42. North America Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Countries (2015-2020)
Figure 44. North America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Countries in 2018
Figure 45. North America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Countries in 2018
Figure 47. United States Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Countries in 2019
Figure 53. Germany Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Regions 2019
Figure 61. China Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Countries in 2019
Figure 68. South America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Countries in 2019
Figure 69. Brazil Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Continuous Subcutaneous Insulin Infusion Devices Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Continuous Subcutaneous Insulin Infusion Devices Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Continuous Subcutaneous Insulin Infusion Devices Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Continuous Subcutaneous Insulin Infusion Devices Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Continuous Subcutaneous Insulin Infusion Devices Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Continuous Subcutaneous Insulin Infusion Devices Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel